Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol
Crossref DOI link: https://doi.org/10.1007/s13300-018-0390-8
Published Online: 2018-03-31
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hinton, William
Feher, Michael
Munro, Neil
de Lusignan, Simon
Funding for this research was provided by:
Novo Nordisk Limited
Article History
Received: 31 January 2018
First Online: 31 March 2018